Ambuang, Decelyn .

HRN: 27-19-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2025
CEFUROXIME 500MG (TAB)
07/21/2025
07/28/2025
PO
500mg
BID X 7 Days
S/P Primary LTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: